FDA to Officially Lower Risk Level for Implanted Blood Access Devices

The FDA issued draft guidance this week to officially lower the risk category for implanted blood access devices used during hemodialysis, updating classification of the devices in light of improvements in medical understanding and the agency’s existing practices.
Mass Device